Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.
In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.
D000368:Aged; D000402:Airway Obstruction / Q000188:drug therapy; D000420:Albuterol / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D011407:Propane / Q000627:therapeutic use; D012138:Respiratory Therapy; D013147:Spirometry
D001993:Bronchodilator Agents; D010276:Parasympatholytics; D001285:Atropine; D000420:Albuterol; D011407:Propane